Johnson & Johnson

The European Union's medicines regulator is expected to recommend drugmaker Johnson & Johnson's COVID-19 vaccine on March 11, Bloomberg News reported https://bloom.bg/3stLMZR on Friday, a move that could give the region its fourth coronavirus vaccine.

A panel of expert advisers to the U.S. Food and Drug Administration is expected to recommend authorization of a one-dose COVID-19 vaccine from Johnson & Johnson on Friday, setting the stage for the unleashing of millions more doses across the country next week.

* J&J SHOT SET TO GET EU NOD IN EARLY MARCH, EASING SUPPLY SQUEEZE - BLOOMBERG NEWS

Bahrain has approved Johnson & Johnson's one-dose COVID-19 vaccine for emergency use, the first country to do so, the National Health Regulatory Authority (NHRA) said on Thursday.

Bahrain has approved Johnson & Johnson's one-dose COVID-19 vaccine for emergency use, the first country to do so, the National Health Regulatory Authority (NHRA) said on Thursday.

The United States expects to roll out three to four million doses of Johnson & Johnson's COVID-19 vaccine next week, pending authorization from the Food and Drug Administration, White House COVID-19 response coordinator Jeff Zients said on Wednesday.

Johnson & Johnson's one-dose COVID-19 vaccine appeared safe and effective in trials, the U.S. Food and Drug Administration said Wednesday, paving the way for its approval for emergency use as soon as this week.

The United States expects to allocate three to four million doses of Johnson & Johnson's COVID-19 vaccine next week, pending approval later this week, the White House's COVID-19 response coordinator, Jeffrey Zients, said on Wednesday.

* U.S. FDA STAFF PUBLISHES BRIEFING DOCUMENTS ON JOHNSON & JOHNSON COVID-19 VACCINE AHEAD OF ADVISORY COMMITTEE MEETING ON FRIDAY

Johnson & Johnson's one-shot COVID-19 vaccine appeared safe and effective in trials, U.S. Food and Drug Administration (FDA) staff said in documents published on Wednesday, paving the way for its approval for emergency use.

Johnson & Johnson expects to be able to ship nearly 4 million doses of its COVID-19 vaccine upon authorization in the U.S., an executive said at a hearing in the U.S. House of Representatives on Tuesday.

South Africa's health minister said on Tuesday that government advisers had organised COVID-19 vaccines into three groups and those considered for "immediate use" were the Johnson & Johnson (J&J), Pfizer and Moderna shots.

South Africa's health minister said on Tuesday that a committee advising the government had grouped COVID-19 vaccines into three groups and those considered for "immediate use" were the Johnson & Johnson, Pfizer and Moderna shots.

Drugmaker Johnson & Johnson set aside $3.9 billion in litigation expenses in 2020, which it said was "primarily associated with talc-related reserves and certain settlements".

French healthcare company Sanofi will provide COVID-19 vaccine manufacturing support to U.S. peer Johnson & Johnson, Sanofi said on Monday.

Johnson & Johnson said on Friday it had submitted data to the World Health Organization (WHO) for emergency use listing of its COVID-19 vaccine, which would allow for wider access of the one-dose shot.

Johnson & Johnson said on Friday it had submitted for emergency use listing of its COVID-19 vaccine to the World Health Organization.

Scientists will meet on Thursday to advise South Africa's government on its next steps after a study suggested the dominant local coronavirus variant may reduce protective antibodies from Pfizer's COVID-19 vaccine by two-thirds.

Johnson & Johnson has only a few million doses of its experimental COVID-19 vaccine in its inventory even as likely U.S. regulatory authorization is only a few weeks away, White House officials said on Wednesday.